The Predictive Value of Interim and Final [18F] Fluorodeoxyglucose Positron Emission Tomography after Rituximab-Chemotherapy in the Treatment of Non-Hodgkin's Lymphoma: A Meta-Analysis

Figure 3

Forest plot of eight included studies in DLBCL (I-PET, OS). Pooled effect (HR) and heterogeneity test of an I-PET-positive scan on OS in DLBCL patients (PET: positron emission tomography; OS: overall survival; HR: hazard ratio; DLBCL: diffuse large B-cell lymphoma).